Product
VRC-ZKADNA090-00-VP
1 clinical trial
6 indications
Indication
Zika virusIndication
Virus DiseasesIndication
Flaviviridae InfectionsIndication
FlavivirusesIndication
Flaviviridae infectionsIndication
RNA Virus InfectionsClinical trial
VRC 705: A Phase 2/2B, Randomized Trial to Evaluate the Safety, Immunogenicity and Efficacy of a Zika Virus DNA Vaccine in Healthy Adults and AdolescentsStatus: Completed, Estimated PCD: 2019-10-04